ALHEMO
ALHEMO
Approved
DIN Number
02536099
Drug Class
Human
Market Date
N/A
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02536099
AIG Number0164481002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B02BX10 CONCIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CONCIZUMABActive
Strength: 60 MG / 1.5 ML
Monograph: CONCIZUMAB